Pronostics signs distribution agreement with Medipan GmbH to sell its lead products in Europe’s largest diagnostics market
Pronostics Ltd has signed a distribution agreement with Medipan GmbH, for its autoimmune disease biomarker assays.
ACE BioSciences Enters Research Collaboration with PATH to Develop Temperature Stable, Oral ETEC Vaccines for the Developing World
ACE BioSciences has entered into a research collaboration with PATH to develop temperature stable ETEC vaccine formulations.
Receptor Logic Teams with Sanofi Pasteur to Develop T Cell Receptor Mimics for Vaccine Research
The collaborative research and exclusive license agreement will develop new technologies for vaccine research and production.
Almac Diagnostics extends agreement with Affymetrix
Almac Diagnostics announces the extension and widening of its ‘Powered by Affymetrix™’ (PbA) agreement with Affymetrix Inc. for an additional 15 years.
Luminex and Abbott Sign Agreement for Global Distribution of the xTAG™ Respiratory Viral Panel
Abbott gains exclusive rights to distribute Luminex’s new xTAG™ RVP worldwide outside the United States and semi-exclusive rights in the United States.
SickKids Scientists Discover Potential Therapeutic Agent for Cancer
Scientists have made an important research discovery which may influence the way that chemotherapy is delivered in certain types of cancer.
Debiopharm Signs Canadian Partner for Sanvar®
Debiopharm signs license and supply agreement with Medical Futures Inc. for the Canadian distribution rights to SANVAR® IR.
Personalized Medicine Can Cut Breast Cancer Risk
The time has come for breast cancer risk assessment, counseling and genetic testing to move from cancer specialists to the realm of primary care, according to a presentation at the AAAS annual meeting.
ImmunoCellular Therapeutics Completes Acquisition of Molecular Antibody Technology
The technology acquired consist a platform technology referred to by MDC as DIAAD™ and certain monoclonal antibody candidates to detect and treat cancer.
Scientists Find Antibody that can Potently Neutralize Two Viruses
NCI scientists have discovered an antibody that neutralizes two highly infectious viruses classified as henipaviruses.